All lobbying filings

INVARIANT LLC

INVARIANT LLC filed a Q3 report for DSM-FIRMENICH on October 19, 2026, reporting $80,000 in lobbying income.

Lobbying for DSM-FIRMENICH · Global science-based company active in nutrition, health, and sustainability.

All filings by INVARIANT LLC · Everything DSM-FIRMENICH has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Environment/Superfund

Discuss regulatory barriers to fragrance commercialization and monitor legislative developments related to new chemical production.

Trade (domestic/foreign)

Educate policymakers on the importance of biomanufacturing and protecting the domestic manufacturing capacity of vitamins.

Foreign Relations

Discuss U.S. assistance in African food programs.

Health Issues

Educate policymakers on the importance of UV filters in sunscreen and on issues related to women's health, maternal health, and infant formula supply.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.